Catheters Market to Reach $133.98B by 2033

The global catheters market is experiencing significant growth driven by rising prevalence of chronic diseases, growing adoption of minimally invasive procedures, and technological advancements. However, the risk of catheter-associated infections & complications is slowing market evolution. Geographically, North America currently has the largest total share of the global market, due to the high prevalence of chronic diseases across the region.

Moreover, Asia Pacific is rapidly emerging as the fastest growing market driven by a combination of a rising burden of chronic diseases and the rapid adoption of innovative medical technologies. Medtronic Plc, Abbott Laboratories, and Boston Scientific Corp are major companies in the market actively pursuing product innovation, partnerships, and developing markets. As demand for catheters grows, manufacturers are developing advanced catheters, so a significant growth in global catheters is expected to emerge, driving down catheter cost, providing greater efficacy while improving global patient outcomes.

You can easily get a sample PDF of the report - https://www.businessmarketinsights.com/sample/BMIPUB00031919

Catheters Market Segmentation Analysis

Key segments that contributed to the derivation of the Catheters market analysis are product, type, coating type, lumen, and end user.

• By product, catheters market is segmented into cardiovascular catheters, intravenous catheters, urological catheters, specialty catheters, neurovascular catheters. The cardiovascular catheters segment dominated the market in 2024.
• By type, catheters market is segmented into Foley catheter, intermittent catheter, IVUS catheter, balloon catheter, and others. The balloon catheter segment dominated the market in 2024.
• By coating type, catheters market is segmented into coated catheters and uncoated catheters. The coated catheters segment dominated the market in 2024.
• By lumen, catheters market is segmented into single-lumen and multi-lumen. The multi-lumen segment dominated the market in 2024.
• By end user, the market is segmented into hospitals & clinics, home care settings, ambulatory surgical centers, diagnostic imaging centers, and others. The hospitals & clinics segment held the largest share of the market in 2024.

Catheters Market Drivers and Opportunities:

Rising Prevalence of Chronic Diseases Driving Catheters Market

The demand for catheters is increasing significantly, primarily driven by a global surge in chronic diseases. As per the World Heart Federation’s May 2023 report, cardiovascular diseases are responsible for approximately 20.5 million deaths each year. Such conditions necessitate procedures, including angiography and angioplasty, which mostly rely on cardiac catheters. Furthermore, the prevalence of urinary incontinence affects an estimated 5% to 70% of the global population, while around 850 million individuals are living with kidney disease, as indicated by the International Society of Nephrology. This surge in urinary and renal issues underscores the growing need for urological catheters to manage bladder function and related treatments.

The World Stroke Organization reports around 12 million new stroke cases annually, often resulting in neurological complications that require catheter intervention for bladder control or various brain procedures. The International Diabetes Federation predicts that by 2024, approximately 589 million adults will be diagnosed with diabetes, which may lead to bladder dysfunction, further enhancing the demand for catheters. As the population continues to age and increasingly live with these chronic conditions, catheters play an essential role in diagnosis, treatment, and ongoing patient care. Consequently, the catheter market is anticipated to experience robust growth in the coming years.

Growing Demand for Home Healthcare and Increasing Adoption of Self-Catheterization

The rising demand for home healthcare and self-catheterization offers a huge opportunity for the players operating in the catheter market. The trend in healthcare is increasingly shifting from hospital-based care to in-home management, particularly for older adults with chronic conditions. As these individuals often face challenges related to diseases such as chronic urinary retention or neurogenic bladder—commonly associated with spinal cord injuries or multiple sclerosis, there is a heightened demand for effective disease management outside of traditional hospital settings.

Patients are increasingly opting for intermittent self-catheterization as a commonly used method for bladder management, as it not only supports enhanced mobility and independence but also mitigates risk concerning urinary tract infections compared to continuous catheterization methods.

Advancements in technology are contributing significantly to this transition, as newer catheter designs often feature specialized coatings and user-friendly designs that facilitate easier insertion and minimize the risk of infection. Telehealth has also proven invaluable in this context, as it enables remote patient education, thereby empowering individuals who utilize self-catheterization to build confidence and adhere to their care plans effectively.

The surge in telehealth usage since 2020 has demonstrated its capacity to deliver healthcare services directly into the home, simplifying the self-care process for many patients. As healthcare systems prioritize patient-centered care, there is an increasing necessity for user-friendly catheters specifically designed for home use and self-catheterization.

Catheters Market News and Key Development:

The catheters market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the key developments in the Catheters market are:

• Medtronic announced its IN. PACT AV drug-coated balloon catheter (DCB) will be reimbursed in Korea starting in May for use in dialysis patients who experience early re-narrowing of their vascular access site. The device is used to treat stenotic lesions -narrowed blood vessels -in patients with end-stage renal disease (ESRD), most of whom undergo hemodialysis, a procedure that filters waste from the blood when the kidneys no longer function. (Source: Medtronic, Company Website, April 2025)
• FDA approved BD CentroVena Central Venous Catheter (CVC) with CentroVena One Insertion System. This approval expands BD's offerings in acute central venous access, designed for short-term use (less than 30 days) to administer fluids, blood products, drugs, and for blood withdrawal and central venous pressure monitoring, including power injection capabilities. (Source: Becton Dickinson and Co, Press Release, April 2025)

Get Premium Research Report at: https://www.businessmarketinsights.com/buy/BMIPUB00031919

About Us:

Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Defense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications.

Contact us:

• If you have any questions about this report or would like further information, please contact us:
• Contact person: Ankit Mathur
• Email: sales@businessmarketinsights.com
• Phone: +16467917070